# Pharmacokinetics, Mass Balance, and Metabolism of [14C]HSK31679 in Healthy Adult Male Volunteers.

> **NCT06258746** · PHASE1 · UNKNOWN · sponsor: **Xizang Haisco Pharmaceutical Co., Ltd** · enrollment: 6 (actual)

## Conditions studied

- Healthy

## Interventions

- **DRUG:** [14C]HSK31679

## Key facts

- **NCT ID:** NCT06258746
- **Lead sponsor:** Xizang Haisco Pharmaceutical Co., Ltd
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2023-12-05
- **Primary completion:** 2023-12-21
- **Final completion:** 2024-12-30
- **Target enrollment:** 6 (ACTUAL)
- **Last updated:** 2024-08-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06258746

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06258746, "Pharmacokinetics, Mass Balance, and Metabolism of [14C]HSK31679 in Healthy Adult Male Volunteers.". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT06258746. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*